“…TNF is a tumor therapeutic factor that activates NF-κB signaling and plays a role in the progression of cancer. Combining with the analysis of the above key targets, it is not difficult to find that TNF plays an indispensable role in the treatment of GC with XSLJZT [ 37 ]. The HIF signaling pathway, which accelerates the progression of GC by regulating several genes that affect the proliferation, metastasis, apoptosis, and angiogenesis of GC cells.…”